Oasmia

Our vision is to improve the treatment of severe diseases in order to provide benefits for both patients and society as a whole.

Read more
Investor meetings

Stockholm 25 november

Göteborg 27 november
Rights issue 2019

Release

Q&A regarding Rights issue in Swedish

Prospectus

Press releases

November 19, 2019 Regulatory press release
Oasmia publishes prospectus in connection with the rights issue of approximately SEK 399 million and updated information included in the prospectus
November 18, 2019
Oasmia invites to investor meetings in connection to the rights issue
November 11, 2019 Regulatory press release
Oasmia resolves on a rights issue of approximately SEK 399 million

All press releases

Financial reports

Calendar

November 25, 2019 Investor meeting in Stockholm
November 27, 2019 Investor meeting in Gothenburg
December 30, 2019 Interim Report May – October 2019

The Share

Follow the share

We uses cookies in order to optimize your use of our website. Read more about cookies.

OK